Document is current
Any future updates will be listed below
-
Authors
Joddrell, Martha https://orcid.org/0000-0002-4088-7043
El-Bouri, Wahbi https://orcid.org/0000-0002-2732-5927
Harrison, Stephanie L. https://orcid.org/0000-0002-8846-0946
Huisman, Menno V. https://orcid.org/0000-0003-1423-5348
Lip, Gregory Y. H. https://orcid.org/0000-0002-7566-1626
Zheng, Yalin https://orcid.org/0000-0002-7873-0922
,
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct01468701 at ClinicalTrials.govnct01671007 at ClinicalTrials.govDocuments that mention this clinical trial
Dabigatran versus vitamin K antagonists for atrial fibrillation in clinical practice: final outcomes from Phase III of the GLORIA-AF registry
https://doi.org/10.1007/s00392-021-01957-1
Impact of early ablation of atrial fibrillation on long-term outcomes: results from phase II/III of the GLORIA-AF registry
https://doi.org/10.1007/s00392-022-02022-1
Machine learning for outcome prediction in patients with non-valvular atrial fibrillation from the GLORIA-AF registry
https://doi.org/10.1038/s41598-024-78120-z
Validating the predictive ability of the 2MACE score for major adverse cardiovascular events in patients with atrial fibrillation: results from phase II/III of the GLORIA-AF registry
https://doi.org/10.1007/s11239-023-02866-y
Comparative effectiveness and safety of non-vitamin K antagonists for atrial fibrillation in clinical practice: GLORIA-AF Registry
https://doi.org/10.1007/s00392-022-01996-2
Design and rationale of Global Registry on Long-Term Oral Antithrombotic Treatment in Patients with Atrial Fibrillation: A global registry program on long-term oral antithrombotic treatment in patients with atrial fibrillation
https://doi.org/10.1016/j.ahj.2013.12.006
nct01937377 at ClinicalTrials.govDocuments that mention this clinical trial
Dabigatran versus vitamin K antagonists for atrial fibrillation in clinical practice: final outcomes from Phase III of the GLORIA-AF registry
https://doi.org/10.1007/s00392-021-01957-1
Impact of early ablation of atrial fibrillation on long-term outcomes: results from phase II/III of the GLORIA-AF registry
https://doi.org/10.1007/s00392-022-02022-1
Machine learning for outcome prediction in patients with non-valvular atrial fibrillation from the GLORIA-AF registry
https://doi.org/10.1038/s41598-024-78120-z
Validating the predictive ability of the 2MACE score for major adverse cardiovascular events in patients with atrial fibrillation: results from phase II/III of the GLORIA-AF registry
https://doi.org/10.1007/s11239-023-02866-y
Comparative effectiveness and safety of non-vitamin K antagonists for atrial fibrillation in clinical practice: GLORIA-AF Registry
https://doi.org/10.1007/s00392-022-01996-2
Design and rationale of Global Registry on Long-Term Oral Antithrombotic Treatment in Patients with Atrial Fibrillation: A global registry program on long-term oral antithrombotic treatment in patients with atrial fibrillation
https://doi.org/10.1016/j.ahj.2013.12.006
Documents that mention this clinical trial
Impact of early ablation of atrial fibrillation on long-term outcomes: results from phase II/III of the GLORIA-AF registry
https://doi.org/10.1007/s00392-022-02022-1
Machine learning for outcome prediction in patients with non-valvular atrial fibrillation from the GLORIA-AF registry
https://doi.org/10.1038/s41598-024-78120-z
Validating the predictive ability of the 2MACE score for major adverse cardiovascular events in patients with atrial fibrillation: results from phase II/III of the GLORIA-AF registry
https://doi.org/10.1007/s11239-023-02866-y
- License Information
-
More Information
Article History
Received: 17 January 2024
Accepted: 29 October 2024
First Online: 7 November 2024
Declarations
:
: The authors declare no competing interests.
